Get the Stockscreener App
315.58
0.27%
-1.3884
Penumbra Inc stock is traded at $315.58, with a volume of 20,550.
It is down -0.27% in the last 24 hours and up +7.83% over the past month.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
See More
Previous Close:
$316.97
Open:
$318.86
24h Volume:
20,550
Relative Volume:
0.05
Market Cap:
$12.35B
Revenue:
$1.24B
Net Income/Loss:
$42.23M
P/E Ratio:
297.72
EPS:
1.06
Net Cash Flow:
$150.33M
1W Performance:
-1.47%
1M Performance:
+7.83%
6M Performance:
+23.28%
1Y Performance:
+31.80%
1-Day Range:
$314.43
$319.78
1-Week Range:
$313.94
$320.35
52-Week Range:
$221.26
$321.38
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
315.40 | 12.41B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
125.23 | 217.08B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.25 | 142.40B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.71 | 135.46B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.62 | 123.74B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
87.21 | 50.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Nov-18-25 | Initiated | Wells Fargo | Underweight |
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Is Penumbra Inc stock a buy during volatile marketsJuly 2025 Momentum & Community Consensus Trade Signals - moha.gov.vn
Reasons to Retain Penumbra Stock in Your Portfolio for Now - Yahoo Finance
New Study Shows CAVT Can Shorten Hospital Stays, May Ease Burden on Hospitals - Diagnostic and Interventional Cardiology
Penumbra stock hits 52-week high at 320.12 USD By Investing.com - Investing.com Nigeria
NeuroOne appoints Penumbra executive Jason Mills to board - Investing.com India
Penumbra stock hits 52-week high at 320.12 USD - Investing.com India
Voya Investment Management LLC Has $37.56 Million Holdings in Penumbra, Inc. $PEN - MarketBeat
Congress Asset Management Co. Has $108.72 Million Position in Penumbra, Inc. $PEN - MarketBeat
How sustainable is Penumbra Inc. stock dividend payoutJuly 2025 Recap & Reliable Breakout Stock Forecasts - Улправда
Will Penumbra Inc. stock reach all time highs in 2025Quarterly Market Summary & Real-Time Buy Zone Alerts - Улправда
Penumbra (NYSE:PEN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
PEN SEC FilingsPenumbra Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Will Penumbra Inc. stock maintain growth storyJuly 2025 Momentum & Advanced Swing Trade Entry Plans - DonanımHaber
Will Penumbra Inc. stock attract more institutional investorsDividend Hike & Free Technical Confirmation Trade Alerts - DonanımHaber
Will Penumbra Inc. stock beat EPS estimatesMarket Trend Report & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Is Penumbra Inc. stock a defensive play in 2025July 2025 Trends & Capital Efficiency Focused Strategies - Улправда
Hedge Fund Bets: Will Penumbra Inc. stock beat EPS estimatesJuly 2025 Momentum & Breakout Confirmation Trade Signals - Улправда
Penumbra (NYSE:PEN) Advances Medical Device Solutions Globally - Kalkine Media
PEN: Truist Securities Maintains 'Buy' Rating and Raises Price T - GuruFocus
Truist Financial Issues Positive Forecast for Penumbra (NYSE:PEN) Stock Price - MarketBeat
Penumbra (NYSE:PEN) Hits New 12-Month High After Analyst Upgrade - MarketBeat
Truist Securities Adjusts Price Target on Penumbra to $370 From $312, Maintains Buy Rating - marketscreener.com
PEN: Today's Analyst Rating Upgrade by JP Morgan | PEN Stock New - GuruFocus
Penumbra (NYSE:PEN) Upgraded by JPMorgan Chase & Co. to "Overweight" Rating - MarketBeat
JPMorgan Upgrades Penumbra to Overweight From Neutral, Lifts Price Target to $370 From $265 - marketscreener.com
Penumbra (NYSE: PEN) executive reports 1,130 shares withheld for taxes - Stock Titan
VP Roberts Surrenders 1,130 Of Penumbra Inc [PEN] - TradingView — Track All Markets
PEN: Canaccord Genuity Raises Price Target for Penumbra to $359 - GuruFocus
RBC Adjusts Price Target on Penumbra to $355 From $325, Maintains Outperform Rating - marketscreener.com
Needham Raises Price Target on Penumbra to $388 From $326, Keeps Buy Rating - marketscreener.com
Penumbra (PEN) Analyst Rating Update: Needham Raises Price Targe - GuruFocus
Penumbra, Inc. $PEN Shares Bought by Texas Permanent School Fund Corp - MarketBeat
Needham raises Penumbra stock price target to $388 on growth outlook - Investing.com UK
Arani Bose sells Penumbra (PEN) shares worth $4.6 million By Investing.com - Investing.com Nigeria
Penumbra price target raised to $345 from $310 at Baird - TipRanks
Penumbra (NYSE:PEN) Director Arani Bose Sells 15,000 Shares - MarketBeat
Here's Why Penumbra (PEN) is a Strong Growth Stock - sharewise.com
Arani Bose sells Penumbra (PEN) shares worth $4.6 million - Investing.com
Penumbra (PEN) director Arani Bose discloses Rule 10b5-1 stock sales - Stock Titan
Dir Bose Sells 15,000 ($4.6M) Of Penumbra Inc [PEN] - TradingView — Track All Markets
Thrivent Financial for Lutherans Sells 34,504 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra: Well-Placed For Above-Average Growth, But Mind The Volatility (NYSE:PEN) - Seeking Alpha
How Investors Are Reacting To Penumbra (PEN) Rising Analyst Optimism On Its Global Growth Strategy - Sahm
Castleark Management LLC Acquires 9,346 Shares of Penumbra, Inc. $PEN - MarketBeat
Is Penumbra Inc a good long term investmentMarket Liquidity Analysis & High Return Trading Ideas - earlytimes.in
Penumbra, Inc. $PEN Shares Bought by Braidwell LP - MarketBeat
Bellevue Group AG Sells 30,467 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (NYSE:PEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Redmile Group LLC Sells 4,025 Shares of Penumbra, Inc. $PEN - MarketBeat
Qube Research & Technologies Ltd Invests $53.82 Million in Penumbra, Inc. $PEN - MarketBeat
Citigroup Upgrades Penumbra (PEN) - Nasdaq
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):